CUTANEOUS LUPUS ERYTHEMATOSUS
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame painful lupus skin flares
Disease control Not yet recruitingThis study is testing whether a pill called enpatoran can safely reduce active skin rashes in people with lupus. About 202 participants with moderate-to-severe lupus skin symptoms will take either enpatoran or a placebo pill for 24 weeks, while continuing their standard lupus med…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New lupus drug candidate ACT100 begins first safety tests in humans
Knowledge-focused Not yet recruitingThis early-stage study tests the safety of a new drug called ACT100 in 48 healthy adults. Participants will receive either the drug or a placebo, and researchers will monitor side effects and how the drug moves through the body. The goal is to find a safe dose before testing it i…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC